Related Experiment Videos
Hypoglycemia associated with preoperative metoprolol administration
Daniel R Brown1, Michael J Brown
1Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
Anesthesia and Analgesia
|October 27, 2004
Summary
Beta-blocker medications like metoprolol can reduce surgical risks for cardiac patients. However, this case highlights a risk of severe hypoglycemia when metoprolol is given just before surgery.
Area of Science:
- Cardiology
- Pharmacology
- Endocrinology
Background:
- Perioperative beta(1)-selective-adrenergic antagonists are used to reduce cardiac events during surgery.
- These medications are generally considered safe for patients with cardiac disease undergoing surgical procedures.
Observation:
- A case report details a patient who received metoprolol, a beta(1)-selective-adrenergic antagonist, immediately before surgery.
- This administration was associated with a severe hypoglycemic event.
Findings:
- The study suggests a potential link between beta(1)-selective-adrenergic antagonist administration and severe hypoglycemia.
- It is postulated that underlying metabolic or energy requirement abnormalities may predispose patients to this adverse effect.
Implications:
- This case highlights the need for vigilance regarding potential hypoglycemia in patients receiving beta(1)-selective-adrenergic antagonists perioperatively.
- Further research may be warranted to explore the mechanisms by which these drugs can precipitate hypoglycemia in susceptible individuals.